Recently though, a successful application of anti-CD19 CAR T-cell therapy (KYV-101) in a female patient with refractory SPS has been reported, as the reduction of anti-GAD65 titers led to stiffness reduction, too. This evidence concerns the gene CD19 and stiff-person syndrome.